Chapter/Section Purchase

Leave This Empty:

Monkeypox Therapeutics Market, Global Outlook and Forecast 2023-2030

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Monkeypox Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Monkeypox Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monkeypox Therapeutics Overall Market Size
2.1 Global Monkeypox Therapeutics Market Size: 2022 VS 2030
2.2 Global Monkeypox Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monkeypox Therapeutics Players in Global Market
3.2 Top Global Monkeypox Therapeutics Companies Ranked by Revenue
3.3 Global Monkeypox Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Monkeypox Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Monkeypox Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monkeypox Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Monkeypox Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Monkeypox Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Monkeypox Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Smallpox Vaccine
4.1.3 Antivirals
4.1.4 Vaccinia Immune Globulin (VIG)
4.2 By Type - Global Monkeypox Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Monkeypox Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Monkeypox Therapeutics Revenue, 2023-2030
4.2.3 By Type - Global Monkeypox Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Monkeypox Therapeutics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 By Application - Global Monkeypox Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Monkeypox Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Monkeypox Therapeutics Revenue, 2023-2030
5.2.3 By Application - Global Monkeypox Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Monkeypox Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Monkeypox Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Monkeypox Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Monkeypox Therapeutics Revenue, 2023-2030
6.2.3 By Region - Global Monkeypox Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Monkeypox Therapeutics Revenue, 2018-2030
6.3.2 US Monkeypox Therapeutics Market Size, 2018-2030
6.3.3 Canada Monkeypox Therapeutics Market Size, 2018-2030
6.3.4 Mexico Monkeypox Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Monkeypox Therapeutics Revenue, 2018-2030
6.4.2 Germany Monkeypox Therapeutics Market Size, 2018-2030
6.4.3 France Monkeypox Therapeutics Market Size, 2018-2030
6.4.4 U.K. Monkeypox Therapeutics Market Size, 2018-2030
6.4.5 Italy Monkeypox Therapeutics Market Size, 2018-2030
6.4.6 Russia Monkeypox Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Monkeypox Therapeutics Market Size, 2018-2030
6.4.8 Benelux Monkeypox Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Monkeypox Therapeutics Revenue, 2018-2030
6.5.2 China Monkeypox Therapeutics Market Size, 2018-2030
6.5.3 Japan Monkeypox Therapeutics Market Size, 2018-2030
6.5.4 South Korea Monkeypox Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Monkeypox Therapeutics Market Size, 2018-2030
6.5.6 India Monkeypox Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Monkeypox Therapeutics Revenue, 2018-2030
6.6.2 Brazil Monkeypox Therapeutics Market Size, 2018-2030
6.6.3 Argentina Monkeypox Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Monkeypox Therapeutics Revenue, 2018-2030
6.7.2 Turkey Monkeypox Therapeutics Market Size, 2018-2030
6.7.3 Israel Monkeypox Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Monkeypox Therapeutics Market Size, 2018-2030
6.7.5 UAE Monkeypox Therapeutics Market Size, 2018-2030
7 Players Profiles
7.1 Chimerix Inc.
7.1.1 Chimerix Inc. Corporate Summary
7.1.2 Chimerix Inc. Business Overview
7.1.3 Chimerix Inc. Monkeypox Therapeutics Major Product Offerings
7.1.4 Chimerix Inc. Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Chimerix Inc. Key News
7.2 SIGA Technologies, Inc.
7.2.1 SIGA Technologies, Inc. Corporate Summary
7.2.2 SIGA Technologies, Inc. Business Overview
7.2.3 SIGA Technologies, Inc. Monkeypox Therapeutics Major Product Offerings
7.2.4 SIGA Technologies, Inc. Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.2.5 SIGA Technologies, Inc. Key News
7.3 Emergent BioSolutions Inc.
7.3.1 Emergent BioSolutions Inc. Corporate Summary
7.3.2 Emergent BioSolutions Inc. Business Overview
7.3.3 Emergent BioSolutions Inc. Monkeypox Therapeutics Major Product Offerings
7.3.4 Emergent BioSolutions Inc. Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Emergent BioSolutions Inc. Key News
7.4 Bavarian Nordic A/S
7.4.1 Bavarian Nordic A/S Corporate Summary
7.4.2 Bavarian Nordic A/S Business Overview
7.4.3 Bavarian Nordic A/S Monkeypox Therapeutics Major Product Offerings
7.4.4 Bavarian Nordic A/S Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Bavarian Nordic A/S Key News
7.5 Hetero Drugs Limited
7.5.1 Hetero Drugs Limited Corporate Summary
7.5.2 Hetero Drugs Limited Business Overview
7.5.3 Hetero Drugs Limited Monkeypox Therapeutics Major Product Offerings
7.5.4 Hetero Drugs Limited Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Hetero Drugs Limited Key News
7.6 Mylan N.V.
7.6.1 Mylan N.V. Corporate Summary
7.6.2 Mylan N.V. Business Overview
7.6.3 Mylan N.V. Monkeypox Therapeutics Major Product Offerings
7.6.4 Mylan N.V. Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Mylan N.V. Key News
7.7 Piramal Enterprises Limited
7.7.1 Piramal Enterprises Limited Corporate Summary
7.7.2 Piramal Enterprises Limited Business Overview
7.7.3 Piramal Enterprises Limited Monkeypox Therapeutics Major Product Offerings
7.7.4 Piramal Enterprises Limited Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Piramal Enterprises Limited Key News
7.8 Olon S.p.A.
7.8.1 Olon S.p.A. Corporate Summary
7.8.2 Olon S.p.A. Business Overview
7.8.3 Olon S.p.A. Monkeypox Therapeutics Major Product Offerings
7.8.4 Olon S.p.A. Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Olon S.p.A. Key News
7.9 Teva Pharmaceutical Industries Limited
7.9.1 Teva Pharmaceutical Industries Limited Corporate Summary
7.9.2 Teva Pharmaceutical Industries Limited Business Overview
7.9.3 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Limited Key News
7.10 CIDIC Company Limited
7.10.1 CIDIC Company Limited Corporate Summary
7.10.2 CIDIC Company Limited Business Overview
7.10.3 CIDIC Company Limited Monkeypox Therapeutics Major Product Offerings
7.10.4 CIDIC Company Limited Monkeypox Therapeutics Revenue in Global Market (2018-2023)
7.10.5 CIDIC Company Limited Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer